Alexandre Passioukov

Vice President Translational Medicine at Pierre Fabre

Alexandre Passioukov leads translational medicine efforts across oncology, CNS and dermatology therapeutic areas at Pierre-Fabre R&D. Previously, Dr. Passioukov was leading translational medicine programs at Roche (Switzerland) with a special focus on immune-oncology drugs. Prior to joining Roche, Alexandre served as Head of Translational Research at EORTC in Brussels, conducting structural translational medicine activities of European clinical research networks.

Alexandre is MD with PhD in biology by Université Catholique de Louvain (UCL), where he was closely involved in the launch of 2 spin-off biotech companies: Coulter Pharma Belgium and Diatos.


Is human skin microbiota a goldmine for personalized diagnostic tests?

  • Personalized medicine - current state in different therapeutic areas: a real ‘patchwork’
  • Dermatology focus: potentials and principle hurdles for personalized diagnostics
  • Immediate challenges for leveraging skin microbiota data and ways out of it, role of AI

Past Presentations

1. CDx & Biomarkers Summit 2019 - Eligibility to CDx: Developping and Implementing Effective Biomarker Strategies for Immuno-Oncology Trials